Navigation Links
Two-time Defending NASCAR Sprint Cup Series Champion Jimmie Johnson Joins the Team at CORD:USE Cord Blood Bank to Help Win the Race for Life
Date:2/12/2008

DAYTONA BEACH, Fla., Feb. 12 /PRNewswire/ -- CORD:USE Cord Blood Bank is proud to announce that two-time defending NASCAR Sprint Cup Series Champion Jimmie Johnson has joined its team. "We're honored to have this NASCAR superstar and terrific person on our team," states Dr. Edward Guindi, President and CEO of CORD:USE. Jimmie Johnson joins CORD:USE as a spokesperson to participate in its "Help Win the Race for Life(TM)" campaign.

"I'm excited about telling people the benefits of umbilical cord blood donation and cord blood stem cell treatments for people in life-or-death situations," says Johnson.

"The fact that umbilical cord blood, which is normally just thrown out after a baby's born, could be donated and used to save someone's life - that just blows me away. We've got over 75 million good-hearted NASCAR fans out there, and together we can make a real difference in CORD:USE's efforts to save lives. I support this with my whole heart, and you better believe when I'm a parent some day, it's something that I'm going to participate in first hand."

Jimmie Johnson joins other NASCAR greats Rusty Wallace and Michael Waltrip, who have played an active role in increasing public awareness of cord blood donation and the dozens of current applications utilizing cord blood stem cells in transplantation.

"They call it The Race for Life, and it's a race team I'm excited to be a part of. CORD:USE's team is made up of many of the top physicians and scientists in this important medical field, which is saving thousands of lives. You know me, every race I'm in, I want to win - and I'm especially determined to win this one," says Johnson.

Cord blood stem cells have already been used to treat more than 10,000 patients, saving thousands of people who would otherwise not have had a chance of survival. There are currently more than 70 different diseases that have been successfully treated utilizing cord blood stem cells.

About CORD:USE Cord Blood Bank

The CORD:USE Cord Blood Bank, headquartered in Orlando, Florida, has assembled a world-class team of scientists and physicians who are pioneers and world leaders in the fields of cord blood stem cell banking and transplantation. CORD:USE is creating a large, ethnically diverse, high- quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant. CORD:USE Cord Blood Bank has entered into agreements with hospitals across the country to provide parents the opportunity to donate their babies' cord blood. CORD:USE makes these cord blood units available to transplanters, throughout the country and around the world, as a critical component in their patients' treatment. CORD:USE lists all of its units on the National Marrow Donor Program's Registry. For more information, please visit our website http://www.corduse.com .


'/>"/>
SOURCE CORD:USE Cord Blood Bank
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
2. Hyperion Therapeutics Secures $40 Million In Series B Round
3. Enobia Pharma Raises $40.1 Million Series B Financing
4. OpGen Announces $23.6 Million Series A Financing
5. Amyris Biotechnologies Announces $70 Million Series B Round
6. Apollo Endosurgery, Inc. Secures $11.5 Million in Series A Financing.
7. Response Genetics CEO to Discuss Advances in Optimizing Therapy through Pharmacogenomics as Part of a Series of Presentations at AACR-NCI-EORTC International Conference
8. VisEn Medical Raises $7 Million in Series B Financing
9. Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting
10. BioVex Closes Second Round of Series E Financing
11. Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... announced today that they have entered into a multiyear collaboration to identify and ... researchers with additional tools for gene editing across all applications. , Under the ...
(Date:10/12/2017)... ... 12, 2017 , ... AMRI, a global contract research, development ... patient outcomes and quality of life, will now be offering its impurity solutions ... new regulatory requirements for all new drug products, including the finalization of ICH ...
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
Breaking Biology Technology:
(Date:4/18/2017)... 18, 2017  Socionext Inc., a global expert in SoC-based imaging ... server, the M820, which features the company,s hybrid codec technology. A ... Tera Probe, Inc., will be showcased during the upcoming Medtec Japan ... at the Las Vegas Convention Center April ... Click here for ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
Breaking Biology News(10 mins):